Summary & Overview
CPT 80377: Definitive Multi-Analyte Drug Testing (7+ Drugs)
CPT code 80377 represents a definitive, multi-analyte toxicology assay that measures seven or more specified drugs or metabolites in a patient specimen. As a laboratory procedure, it supports clinical decision-making in pain management, substance use monitoring, forensic testing, and medication compliance programs. Nationally, definitive multi-analyte testing matters because it provides confirmatory results used for treatment planning, regulatory compliance, and medico-legal documentation.
Key payers discussed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of payer coverage patterns, utilization benchmarks where available, and the clinical context in which this test is used. The publication also addresses coding considerations, billing service line implications, and common modifiers and billing practices relevant to laboratory services.
This resource is intended for billing managers, laboratory directors, and policy analysts seeking a concise reference on CPT code 80377: what the code denotes, typical sites of service, and the payer landscape. Data not available in the input will be clearly noted in respective sections.
Billing Code Overview
CPT code 80377 describes a laboratory test in which a lab analyst measures the presence or amount of seven or more definitive drugs in a patient specimen. This is a multi-analyte toxicology screen intended to detect and quantify multiple definitive drugs or metabolites in a single specimen.
Service type: Laboratory — Definitive drug testing, multi-analyte
Typical site of service: Clinical laboratory or hospital laboratory
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 28-year-old patient presents to an outpatient addiction medicine clinic for evaluation after a workplace incident suggesting possible illicit drug use. The clinician orders a comprehensive urine drug screen to detect the presence and approximate concentration of multiple definitive drugs and metabolites. The specimen is collected under chain-of-custody procedures, labeled, and sent to a clinical laboratory. In the laboratory workflow, a medical technologist or lab analyst performs a definitive multi-analyte assay that quantifies or confirms seven or more specific drugs or drug classes using methods such as gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS). Results are reviewed by the laboratory director and reported to the ordering provider. Typical sites of service include hospital laboratories, independent reference laboratories, outpatient clinics with send-out testing, and forensic or occupational health testing centers. The service is used for substance use disorder monitoring, pre-employment or forensic testing, pain management monitoring, and suspected overdose evaluation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When only the professional interpretation/reporting component is billed separately by the physician or pathologist |